Researchers at the University of Milan and King’s College, London thoroughly reviewed the literature available on Medline and Cochrane regarding the use of benzodiazepines in anxiety, affective and psychotic disorders, as well as the available literature on benzos’ adverse effects. They conclude that the wide use that benzos have achieved in psychiatric and non-psychiatric disorders is not supported by the scientific evidence. There is “robust” evidence for short-term use in panic disorder and generalized anxiety disorder, “intermediate” evidence for social anxiety disorder and “poor” evidence for PTSD and OCD. However, the side-effects found in long-term use, and the risks of abuse and withdrawal effects “recommend a more cautious use of BZDs (short-term) than previously achieved.” Results will appear in European Psychiatry.
Mad in America hosts blogs by a diverse group of writers. These posts are designed to serve as a public forum for a discussion—broadly speaking—of psychiatry and its treatments. The opinions expressed are the writers’ own.
Mad in America has made some changes to the commenting process. You no longer need to login or create an account on our site to comment. The only information needed is your name, email and comment text. Comments made with an account prior to this change will remain visible on the site.